Legend Biotech Ownership | Who Owns Legend Biotech?

Overview Forecast RevenueFinancials Chart Transcripts

Legend Biotech Ownership Summary

Legend Biotech is owned by 49.97% institutional investors, 1.31% insiders, and 48.72% retail investors. Fmr is the largest institutional shareholder, holding 9.68% of LEGN shares. Invesco Emerging Markets Equity is the top mutual fund, with 1.62% of its assets in Legend Biotech shares.

LEGN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Legend Biotech	49.97%	1.31%	48.72%
Sector	Healthcare Stocks	88.01%	8.90%	3.09%
Industry	Biotech Stocks	109.70%	8.77%	-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	17.62M	9.68%	$780.46M
Price t rowe associates inc /md/	11.49M	6.31%	$508.86M
Ra capital management	7.51M	4.12%	$332.48M
Hhlr advisors	6.64M	3.65%	$293.93M
Blackrock	5.72M	3.14%	$253.40M
Westfield capital management co lp	4.77M	2.62%	$211.36M
Blackrock funding, inc. /de	4.61M	2.52%	$149.96M
Wellington management group llp	2.81M	1.54%	$124.43M
Janus henderson group	2.36M	1.30%	$104.47M
Capital investors	2.16M	1.19%	$95.79M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Johnson & johnson	814.59K	9.00%	$36.08M
Superstring capital management lp	154.66K	8.64%	$6.85M
Matthews capital management	1.19M	7.89%	$38.58M
Hhlr advisors	6.64M	7.25%	$293.93M
Cutter capital management, lp	343.13K	4.59%	$15.20M
Ra capital management	7.51M	4.40%	$332.48M
Tri locum partners lp	356.53K	3.99%	$15.79M
Braidwell lp	1.67M	2.32%	$73.95M
Boxer capital	600.00K	1.40%	$26.57M
Decheng capital	98.56K	1.34%	$4.37M

Top Buyers

Holder	Shares	% Assets	Change
Westfield capital management co lp	4.77M	1.04%	2.53M
Fmr	17.62M	0.05%	1.47M
Hhlr advisors	6.64M	7.25%	651.95K
Ra capital management	7.51M	4.40%	645.84K
Ameriprise financial	657.39K	0.01%	563.67K

Top Sellers

Holder	Shares	% Assets	Change
Capital world investors	-	-	-2.39M
Paradigm biocapital advisors lp	-	-	-1.20M
Timessquare capital management	2.91K	0.00%	-1.16M
Holocene advisors, lp	-	-	-761.63K
Pfm health sciences, lp	-	-	-734.29K

New Positions

Holder	Shares	% Assets	Change	Value
Balyasny asset management	451.96K	0.04%	451.96K	$20.02M
Point72 asset management	304.52K	0.04%	304.52K	$13.49M
Los angeles capital management	172.44K	0.02%	172.44K	$5.61M
Superstring capital management lp	154.66K	8.64%	154.66K	$6.85M
Centerbook partners lp	154.07K	0.42%	154.07K	$6.82M

Sold Out

Holder	Change
Smartleaf asset management	-21.00
Vermillion & white wealth management group	-25.00
Macroview investment management	-36.00
Peak6 investments	-200.00
Lazard asset management	-380.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	217	14.81%	91,247,449	-0.49%	49	1.98%	116	5.45%	63	31.25%
Jun 30, 2024	186	-11.85%	91,687,379	5.90%	50	2.08%	107	-5.31%	48	-23.81%
Mar 31, 2024	211	-7.05%	86,578,276	0.79%	49	8.08%	113	-13.08%	63	6.78%
Dec 31, 2023	227	5.09%	85,900,395	-0.06%	24	1.03%	130	36.84%	59	-16.90%
Sep 30, 2023	216	6.93%	85,954,399	1.67%	48	1.87%	95	-12.04%	71	7.58%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Invesco Emerging Markets Equity	2.96M	1.62%	929.05K
Invesco Developing Markets A	2.96M	1.62%	-
Fidelity Select Health Care	2.62M	1.43%	-
Fidelity Growth Compy Commingled Pl O	2.43M	1.32%	-
T. Rowe Price US Growth Stock Composite	2.32M	1.26%	-77.22K
T. Rowe Price Growth Stock	2.27M	1.24%	-32.51K
Fidelity Advisor Health Care I	1.60M	0.87%	-
MFS Mid Cap Growth A	1.58M	0.86%	-
MFS Mid Cap Growth Equity	1.58M	0.86%	15.32K
T. Rowe Price US Large-Cap Growth Equity	1.48M	0.81%	-8.75K

LEGN Ownership FAQ

Who Owns Legend Biotech?

Legend Biotech shareholders are primarily institutional investors at 49.97%, followed by 1.31% insiders and 48.72% retail investors. The average institutional ownership in Legend Biotech's industry, Biotech Stocks , is 109.70%, which Legend Biotech falls below.

Who owns the most shares of Legend Biotech?

Legend Biotech’s largest shareholders are Fmr (17.62M shares, 9.68%), Price t rowe associates inc /md/ (11.49M shares, 6.31%), and Ra capital management (7.51M shares, 4.12%). Together, they hold 20.12% of Legend Biotech’s total shares outstanding.

Does Blackrock own Legend Biotech?

Yes, BlackRock owns 3.14% of Legend Biotech, totaling 5.72M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 253.4M$. In the last quarter, BlackRock increased its holdings by 337.25K shares, a 6.26% change.

Who is Legend Biotech’s biggest shareholder by percentage of total assets invested?

Johnson & johnson is Legend Biotech’s biggest shareholder by percentage of total assets invested, with 9.00% of its assets in 814.59K Legend Biotech shares, valued at 36.08M$.

Who is the top mutual fund holder of Legend Biotech shares?

Invesco Emerging Markets Equity is the top mutual fund holder of Legend Biotech shares, with 1.62% of its total shares outstanding invested in 2.96M Legend Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools